atovaquone
Generic: atovaquone
Labeler: atlantic biologicals corp.Drug Facts
Product Profile
Brand Name
atovaquone
Generic Name
atovaquone
Labeler
atlantic biologicals corp.
Dosage Form
SUSPENSION
Routes
Active Ingredients
atovaquone 750 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
17856-8631
Product ID
17856-8631_40331587-a465-4ac5-e063-6294a90a7ec6
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA210692
Listing Expiration
2026-12-31
Marketing Start
2018-10-11
Pharmacologic Class
Established (EPC)
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
178568631
Hyphenated Format
17856-8631
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
atovaquone (source: ndc)
Generic Name
atovaquone (source: ndc)
Application Number
ANDA210692 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 750 mg/5mL
Packaging
- 50 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-8631-1) / 5 mL in 1 CUP, UNIT-DOSE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "40331587-a465-4ac5-e063-6294a90a7ec6", "openfda": {"nui": ["N0000175482", "N0000175485"], "unii": ["Y883P1Z2LT"], "rxcui": ["308429"], "spl_set_id": ["40331de7-819e-5965-e063-6294a90ac91d"], "pharm_class_epc": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "manufacturer_name": ["ATLANTIC BIOLOGICALS CORP."]}, "finished": true, "packaging": [{"sample": false, "description": "50 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-8631-1) / 5 mL in 1 CUP, UNIT-DOSE", "package_ndc": "17856-8631-1", "marketing_start_date": "20251001"}], "brand_name": "Atovaquone", "product_id": "17856-8631_40331587-a465-4ac5-e063-6294a90a7ec6", "dosage_form": "SUSPENSION", "pharm_class": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "product_ndc": "17856-8631", "generic_name": "Atovaquone", "labeler_name": "ATLANTIC BIOLOGICALS CORP.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Atovaquone", "active_ingredients": [{"name": "ATOVAQUONE", "strength": "750 mg/5mL"}], "application_number": "ANDA210692", "marketing_category": "ANDA", "marketing_start_date": "20181011", "listing_expiration_date": "20261231"}